Diagnosis: Drug-induced linear IgA bullous dermatosis
A 62-year-old male developed a vesicular eruption on his trunk and extremities following the initiation of vancomycin therapy for a suspected bacterial infection. The lesions exhibited a characteristic 'string-of-pearls' appearance, prompting further investigation into the etiology of his skin condition, ultimately leading to the diagnosis of drug-induced linear IgA bullous dermatosis.
A 62-year-old male presented with a 2-week history of pruritic vesicular lesions on his trunk and extremities. The patient reported that the lesions appeared shortly after starting vancomycin therapy for a suspected skin infection. On examination, the skin was notable for tense bullae in a linear configuration, with surrounding erythema.Age: 62 years oldSex: MaleDuration: 2 weeksKey complaint: Pruritic vesicular lesionsExam findings: Tense bullae with a 'string-of-pearls' appearance
The patient’s eruption began approximately 10 days after the initiation of vancomycin. He had no prior history of bullous disorders and denied any known drug allergies. His medical history included hypertension and type 2 diabetes, both well-controlled on medication. There was no significant family history of skin diseases, and he reported no recent travel or exposure to new medications except for vancomycin.Onset: 10 days after starting vancomycinTriggers: Recent antibiotic usePrior treatments: None for skin conditionRelevant past medical history: Hypertension, type 2 diabetesSocial history: Non-smoker, no recent travel
Acute / First-Line ManagementDiscontinue vancomycin immediately to prevent further exacerbation.Initiate treatment with dapsone at a dosage of 100 mg daily to manage inflammation and blistering.Consider systemic corticosteroids, such as prednisone at 1 mg/kg/day, for severe cases to control symptoms rapidly.Workup and Diagnostic ConfirmationPerform a skin biopsy for direct immunofluorescence to confirm the presence of linear IgA deposits along the basement membrane zone.Conduct serological tests to rule out other autoimmune blistering diseases.Evaluate for any underlying conditions that may predispose to drug-induced reactions.Long-Term ManagementContinue dapsone therapy at a maintenance dose of 50-100 mg daily as needed based on clinical response.Monitor for potential adverse effects of long-term dapsone use, including hemolysis.Provide education on avoiding known triggers and maintaining skin care to minimize irritation.
Bullous pemphigoid: Typically presents in older adults with subepithelial bullae and may be confirmed by immunofluorescence showing IgG and C3 at the basement membrane.Dermatitis herpetiformis: Associated with gluten sensitivity, presenting as grouped vesicles on extensor surfaces; direct immunofluorescence shows IgA deposits.Epidermolysis bullosa acquisita: Presents with tense blisters and scarring; immunofluorescence reveals IgG and C3 at the basement membrane.Contact dermatitis: Vesicular eruptions due to allergic contact; history of exposure to allergens may aid diagnosis.Vesicular hand-foot-and-mouth disease: Often presents in children with vesicles; viral etiology distinguishes it from autoimmune causes.Staphylococcal scalded skin syndrome: Characterized by widespread blistering and desquamation due to toxins from Staphylococcus aureus.Herpes simplex virus infection: May present with vesicles; PCR or culture can confirm the diagnosis.Fixed drug eruption: Characterized by recurrent lesions at the same site after exposure to a specific medication.
High-Yield PearlsDrug-induced: Linear IgA bullous dermatosis can occur following the use of specific medications, especially antibiotics like vancomycin.Clinical appearance: The 'string-of-pearls' appearance of lesions is a hallmark of this condition and aids in early recognition.Immunofluorescence: Direct immunofluorescence is critical in confirming the diagnosis by demonstrating linear IgA deposits.Management: Dapsone is a first-line treatment, with systemic corticosteroids reserved for severe cases.Monitoring: Regular monitoring is essential to manage potential side effects of dapsone and to assess clinical improvement.Recognizing the clinical features of drug-induced linear IgA bullous dermatosis can lead to prompt diagnosis and effective management.
Tags: linear IgA, drug-induced